high-risk mds follonig car t cells in patients with rr dlbcl
Published 1 year ago • 219 plays • Length 40:20Download video MP4
Download video MP3
Similar videos
-
1:38:01
post #ash21 by the iach: car-t cells
-
1:53
car-t cells in lymphoid diseases: the patient journey
-
47:52
gut microbiome correlates of response and toxicity following anti cd19 car t cell therapy
-
1:10
car-t therapy for high-risk mcl patients
-
34:53
engineered t cell with cars and tcrs for hematologic malignancy
-
7:14
frederick locke, md: car t-cell therapy in relapsed/refractory nhl
-
3:18
allogeneic car-nk cell therapy in r/r aml/mds
-
58:22
myelodysplastic syndromes: key take-home messages from eha and asco 2024
-
57:44
understanding car t cell therapy for the treatment of lymphoma
-
1:15
car t-cells in hematological malignancies
-
1:34
car t-cell immunotherapy
-
26:36
2021 mdons | hematology advances in care | car t-cell therapy
-
4:59
the role of car-t
-
1:16
hurdles to car-t therapy for mds & aml: t-cell fitness & lack of a uniform target antigen
-
2:48
outcomes of autosct, allosct & car-t cell therapy in patients with tp53-altered mcl
-
1:35
key mechanisms of resistance to car t-cell therapy